Recently, Baheal Medical (301015.SZ) officially launched a new product by its imported calcium brand D·Cal Golden Sachets® Liquid Calcium (hereinafter referred to as "D·Cal Golden Sachets"). Committed to optimizing medicinal scenarios through technological innovation, Baheal Medical delves deep into the health needs of consumers, determined to provide them with more professional and high-quality product options.
D·Cal, a brand that Baheal Medical has been operating since its inception, focuses on the niche category of "imported calcium" based on its insight and research into the category. Baheal Medical is engaged in professional academic promotion and precise consumer education, bridging the gap between the brand and consumers. After more than two decades of meticulous cultivation, D·Cal has won widespread recognition and trust from consumers for its insistence on high quality and professional height management services. It has maintained a leading position in the sales of imported calcium for seven consecutive years, becoming a renowned leader in the imported calcium supplement market. Facing the ever-changing market and diversified calcium supplement needs of consumers, D·Cal persists in putting consumers at the center. It deeply studies consumers' bone health and calcium nutrition supplementation, continually launching innovative products to enrich and perfect its product line, so as to meet the calcium supplement needs of different groups. D·Cal has successfully created calcium supplements for various groups, including pregnant women, infants, children, adults, and the elderly, and continues to push for research and development innovation to build a diversified product structure. The newly launched D·Cal Golden Sachets product, based on the original product system, not only adopts a more convenient and safe individual strip form for packaging, easy for children's supplementation at any time, but also importantly adds Vitamin D3 and Vitamin K2 to help skeletal formation in growing children. Leveraging Baheal Medical's professional commercialization capabilities and strong marketing network resources, D·Cal has partnered with chains and O2O medical platforms like Shuyu Pingmin and Dingdang Health to rapidly expand its new products. These efforts cater to the ever-growing calcium supplement demands of consumers and continuously optimize their calcium supplement experience. As the leading healthcare brands commercialization platform in A-shares , Baheal Medical's core business focuses on brand operations. In addition to being at the forefront with the imported calcium brand D·Cal, Baheal Medical has successfully created and operated numerous well-known products such as MiTe for indigestion, HYLO for artificial tears, Nutrasumma for dietary nutritional supplements, and effective skincare products. This has resulted in a rich category matrix based on four major categories, including OTC and healthcare, OTX and prescription drugs,oncology drugs, and high-end medical devices. In the future, Baheal Medical continues to focus on optimizing medical scenarios, fully leveraging its core competitiveness of the "Brand Highway" and introducing more high-quality, innovative pharmaceutical products and services to the market. This initiative is part of Baheal Medical's ongoing commitment to providing robust healthcare assurance for the people of China.
